Impact of the Ki-67 labeling index and p53 expression status on disease-free survival in pT1 urothelial carcinoma of the bladder

BACKGROUND: The identification of protein biomarkers to guide treatment decisions regarding adjuvant therapies for high-risk non-muscle-invasive bladder cancer (NMIBC) has been of increasing interest. Evidence of the impact of tumor suppressor gene product p53 and cell proliferation marker Ki-67 on...

Descripción completa

Detalles Bibliográficos
Autores principales: Vetterlein, Malte W., Roschinski, Julia, Gild, Philipp, Marks, Phillip, Soave, Armin, Doh, Ousman, Isbarn, Hendrik, Höppner, Wolfgang, Wagner, Walter, Shariat, Shahrokh F., Brausi, Maurizio, Büscheck, Franziska, Sauter, Guido, Fisch, Margit, Rink, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5760387/
https://www.ncbi.nlm.nih.gov/pubmed/29354488
http://dx.doi.org/10.21037/tau.2017.11.10

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5760387/
https://www.ncbi.nlm.nih.gov/pubmed/29354488
http://dx.doi.org/10.21037/tau.2017.11.10

Ejemplares similares